NDC 66104-8200-0 - Nicarb
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66104-8200
- Requested NDC
- 66104-8200-0
- Package NDCs from labels
- 66104-8200-0
- Manufacturer
- Phibro Animal Health
- Effective date
- 2023-11-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nicarb - Phibro Animal Health | Phibro Animal Health | 2023-11-06 | OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66104-8200-0 | Nicarb | 22.68 kg in 1 BAG | POWDER | 22.68 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66104-8200 | NICARB (NICARBAZIN) POWDER [PHIBRO ANIMAL HEALTH] | 10 | 1 package rows | 20231107_5a397494-e980-4f45-80e6-ab99ffdaf48a.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NICARBAZIN | ACTIVE INGREDIENT | 11P9NUA12U | NICARB (NICARBAZIN) POWDER [PHIBRO ANIMAL HEALTH] | 6 | |
| 4,4'-DINITROCARBANILIDE | ACTIVE MOIETY | 9IDD210E75 | NICARB (NICARBAZIN) POWDER [PHIBRO ANIMAL HEALTH] | 6 | |
| SOYBEAN OIL | INACTIVE INGREDIENT | 241ATL177A | NICARB (NICARBAZIN) POWDER [PHIBRO ANIMAL HEALTH] | 6 | |
| WHEAT MIDDLINGS | INACTIVE INGREDIENT | 12H8QE0WQI | NICARB (NICARBAZIN) POWDER [PHIBRO ANIMAL HEALTH] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NutriLipid I.V. Fat Emulsion | SOYBEAN OIL | B. Braun Medical Inc. | 193290b1-a0a1-4054-a22a-de5c9e7a8b73 | 2026-07-10 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | ProPharma Distribution | 48c12fbe-c5e8-a1fc-e063-6294a90a15ae | 2026-01-19 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | 61e025f1-a38e-4af2-9e18-13ea12977cf5 | 2025-11-19 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | ProPharma Distribution | 42dffe5a-892b-03ec-e063-6394a90ae50c | 2025-11-05 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | 98460eae-5195-48d2-ab73-00d276879ef6 | 2025-10-09 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | bdcc364b-77b2-4939-8add-03e5396d46c2 | 2025-10-08 | Warnings, Adverse reactions | 241ATL177A |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | 241ATL177A |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | 241ATL177A |
| Smoflipid | SMOFLIPID | Fresenius Kabi USA, LLC | e0e9d917-ff6f-488e-a6a8-0ad59dd17d80 | 2025-08-15 | Warnings, Adverse reactions | 241ATL177A |
| Clinolipid | OLIVE OIL AND SOYBEAN OIL | Baxter Healthcare Corporation | ae98eb03-c0e7-49d1-b024-77968e3d9d6e | 2025-07-24 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare CORP | 069460a5-3e9a-428f-b2dc-3405690f4fd7 | 2022-07-25 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | 55609586-f0b4-42e6-8dd9-cd090afb5dca | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | a69c82da-15ba-4d4d-8d7f-871dc3981eb8 | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I. V. FAT EMULSION | Baxter Healthcare Corporation | dd269651-30e8-43f0-880f-484346eaafeb | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | cbd3396e-6b85-41bf-82d2-940beba86686 | 2019-01-09 | Boxed warning, Warnings, Adverse reactions | 241ATL177A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.